Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Medtronic
MDT
|
+$464M |
| 2 |
Exxon Mobil
XOM
|
+$299M |
| 3 |
FedEx
FDX
|
+$289M |
| 4 |
Netflix
NFLX
|
+$273M |
| 5 |
Micron Technology
MU
|
+$265M |
Top Sells
| 1 |
Amazon
AMZN
|
+$290M |
| 2 |
Electronic Arts
EA
|
+$285M |
| 3 |
Mastercard
MA
|
+$269M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$245M |
| 5 |
Johnson & Johnson
JNJ
|
+$237M |
Sector Composition
| 1 | Healthcare | 15.71% |
| 2 | Technology | 15.39% |
| 3 | Financials | 11.4% |
| 4 | Industrials | 9.47% |
| 5 | Consumer Staples | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPMC
3276
DELISTED
Blueprint Medicines
BPMC
| – | – |
-13,000
| Closed | -$659K |
|
3277
Cadiz
CDZI
$303M
| – | – |
-90,036
| Closed | -$1.22M |
|
3278
CF Industries
CF
$13.7B
| – | – |
-1,255,650
| Closed | -$35.1M |
|
3279
Coherus Oncology, Inc. Common Stock
CHRS
$159M
| – | – |
-21,900
| Closed | -$314K |
|
3280
C.H. Robinson
CHRW
$14.9B
| – | – |
-515,308
| Closed | -$35.4M |
|
3281
Cigna
CI
$80.3B
| – | – |
-555,100
| Closed | -$92.9M |
|
3282
Ciena
CIEN
$16.8B
| – | – |
-688,474
| Closed | -$17.2M |
|
3283
Core Laboratories
CLB
$582M
| – | – |
-116,200
| Closed | -$11.8M |
|
3284
Clearside Biomedical
CLSD
$26.6M
| – | – |
-80,200
| Closed | -$731K |
|
3285
Comcast
CMCSA
$124B
| – | – |
-220,576
| Closed | -$8.59M |
|
3286
Cummins
CMI
$54.8B
| – | – |
-310,900
| Closed | -$50.4M |
|
3287
Compass Minerals
CMP
$794M
| – | – |
-151,300
| Closed | -$9.88M |
|
3288
CommScope
COMM
$3.59B
| – | – |
-332,400
| Closed | -$12.6M |
|
3289
Capri Holdings
CPRI
$2.54B
| – | – |
-621,000
| Closed | -$22.5M |
|
|
CRESY
3290
Cresud
CRESY
$526M
| – | – |
-90,632
| Closed | -$1.6M |
|
3291
Curtiss-Wright
CW
$18.2B
| – | – |
-272,000
| Closed | -$25M |
|
3292
Crane NXT
CXT
$3.54B
| – | – |
-628,774
| Closed | -$17.3M |
|
3293
Community Health Systems
CYH
$415M
| – | – |
-487,493
| Closed | -$4.86M |
|
3294
Cyclacel Pharmaceuticals
CYCC
$14.9M
| – | – |
-1
| Closed | -$184K |
|
3295
Deere & Co
DE
$130B
| – | – |
-152,400
| Closed | -$18.8M |
|
3296
Dollar General
DG
$23B
| – | – |
-844,300
| Closed | -$60.9M |
|
3297
Dynagas LNG Partners
DLNG
$141M
| – | – |
-95,000
| Closed | -$1.45M |
|
3298
Dollar Tree
DLTR
$20.3B
| – | – |
-1,801,303
| Closed | -$126M |
|
3299
First Financial Bankshares
FFIN
$5.13B
| – | – |
-18,308
| Closed | -$405K |
|
3300
Fifth Third Bancorp
FITB
$30.1B
| – | – |
-430,026
| Closed | -$11.2M |
|